Renin - angiotensin (RA) drugs (Angiotensin Converting Enzyme Inhibitors - ACEIs - and Angiotensin Receptor Blockers - ARBs) are accepted treatments for hypertension and Congestive Heart Failure. Coughing can occur with ACEIs leading to development of ARBs. Trials showed though discontinuation due to coughing in a minority of patients on ACEIs (2- - 3%). ARB prescribing restrictions in Austria as higher costs than ACEIs moderated utilisation. Other demand side measures in Spain (Catalonia) following generic ACEIs also moderated ARB utilisation.
|Journal||Pharmacoepidemiology and Drug Safety|
|Publication status||Published - 2011|
|Event||27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management - Chicago, United States|
Duration: 14 Aug 2011 → 17 Aug 2011
- receptor blockers
- drug utilisation
Voncina, L., Godman, B. B., Vlahovic-Palcevski, V., Bennie, M., & Bishop, I. (2011). Recent policies to enhance Renin-angiotensin prescribing efficiency in Europe; implications for the future. Pharmacoepidemiology and Drug Safety, 20(Suppl.1), S210-S210. . https://doi.org/10.1002/pds.2206